NICOLETTE HAMPTON: Open Payments
NPI 1184083818 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 25 payments from 11 companies in 2025. Trend: 2023 $414 · 2024 $269 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $158 |
| Astellas Pharma US Inc | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Amgen Inc. | 2 | $29 |
| Novo Nordisk Inc | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $19 |
Products named: VRAYLAR, Veozah, QULIPTA, FANAPT, INSPIRE, GEMTESA, WATCHMAN Access System, UBRELVY.
Industry payments across ID — which companies pay providers there.
